MEOX2 and non-small cell lung carcinoma: These findings suggest that decreased levels of the histone marker H3K27me3 and increased levels of H3K4me3 are correlated with MEOX2 and TWIST1 overexpression, probably associated to clinical response prognosis in NSCLC patients (Table 1), or involved in the acquisition of chemoresistance.